Page 172 - Phytochemistry 2 (06-PG 605)
P. 172
Current regimens, which combine HHT with cytarabine and
daunorubicin, induce up to 85% ofcomplete response in
acute myeloid leukemia (AML), after only two cycles .
Omacetaxine mepesuccinate is also being studiedin the
treatment of other types of cancer
